Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Lymphoma 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia 26Lymphoma, Large B-Cell, Diffuse 22Breast Neoplasms 21Lymphoma, Follicular 18Leukemia, Myeloid, Acute 18Burkitt Lymphoma 16Multiple Myeloma 15Lymphoma, Non-Hodgkin 15Lymphoma, Mantle-Cell 14Leukemia, Lymphocytic, Chronic, B-Cell 13Hodgkin Disease 13Lymphoma, Large-Cell, Immunoblastic 12Neuroblastoma 11Melanoma 11Myelodysplastic Syndromes 10Lymphoma, B-Cell, Marginal Zone 10Neoplasms, Plasma Cell 9Sarcoma 8Leukemia, Myeloid, Chronic-Phase 8Neutropenia 7Central Nervous System Neoplasms 7Myeloproliferative Disorders 6Medulloblastoma 6Leukemia, Myelomonocytic, Acute 6Congenital Abnormalities 6Waldenstrom Macroglobulinemia 5Neoplasms 5Leukemia, Myelomonocytic, Chronic 5

Interventions

Radiotherapy 4Cisplatin 4Paclitaxel 3Gemcitabine 3Fluorouracil 3Oxaliplatin 2fluoromisonidazole 1dl1520 1Semaxinib 1Rubidium-82 1Ritonavir 1Nivolumab 1Nicotine 1Magnetic Resonance Spectroscopy 1Leucovorin 1Irinotecan 1Indinavir 1Immunohistochemistry 1Fluorodeoxyglucose F18 1Filgrastim 1Endoscopic Mucosal Resection 1EBV-associated membrane antigen, Epstein-Barr virus 1Docetaxel 1Bronchoscopy 1Bortezomib 1Amifostine 15-fluoropentyl-2-methylmalonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Nasopharyngeal Neoplasms × Filgrastim × Clear all
NCT00004164 2009-02-09

Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx

National Cancer Institute (NCI)

Phase 2 Unknown
Head & Neck

Head and Neck Neoplasms, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡